A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Clinical trial NCT06509984 · RECRUITING

Trial details

NCT number: NCT06509984
Sponsor: Centre Hospitalier Universitaire de Nice
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex Genodermatosis

Start date: 2024-08-06
Primary completion: 2025-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.